Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Food Chem Toxicol ; 60: 297-301, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23933361

ABSTRACT

Due to undesirable hazardous interactions with biological systems, we evaluated the effect of silver nanoparticles (AgNPs) intake on oxidative stress and inflammation. Rats received for 81 days a standard diet (Controls) or a standard diet plus 500 mg/d/kg BW AgNPs. We assayed plasma lipids, and oxidative stress was assessed by measuring liver and heart superoxide anion production (O2°â») and liver malondialdehyde levels (MDA). Antioxidant status was appraised using plasma paraoxonase activity (PON), plasma antioxidant capacity (PAC) and liver superoxide dismutase activity (SOD). Liver inflammatory cytokines TNFα and IL-6 levels and plasma alanine aminotransferase (ALT) were assayed. Compared with Controls, AgNPs raised cholesterolemia (9.5%), LDL-cholesterol (30%), and lowered triglycerides (41%). They also increased liver (30%) and cardiac (41%) O2°â» production, reduced PON activity (15%) and raised liver TNFα (9%) and IL-6 (∼12%). Plasma ALT activity rose (12%) after treatment with AgNPs. However, PAC and liver MDA and SOD activity were unchanged. These features indicate that exposure to 500 mg/d/kg BW of AgNPs results in liver damage by a dysregulation of lipid metabolism, highlighting liver and heart as the most sensitive organs to the deleterious effects. Our findings also demonstrate for the first time the oxidative and inflammatory effects of dietary AgNPs.


Subject(s)
Inflammation/pathology , Metal Nanoparticles/administration & dosage , Oxidative Stress/drug effects , Silver/administration & dosage , Administration, Oral , Alanine Transaminase/blood , Animals , Antioxidants/metabolism , Cholesterol/blood , Heart/drug effects , Hypercholesterolemia/chemically induced , Hypercholesterolemia/pathology , Inflammation/chemically induced , Interleukin-6/metabolism , Lipid Metabolism/drug effects , Liver/drug effects , Liver/pathology , Liver Diseases/etiology , Liver Diseases/pathology , Male , Malondialdehyde/metabolism , Metal Nanoparticles/chemistry , Rats , Rats, Sprague-Dawley , Silver/chemistry , Superoxide Dismutase/metabolism , Superoxides/metabolism , Triglycerides/blood , Tumor Necrosis Factor-alpha/metabolism
2.
Med Eng Phys ; 31(3): 392-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18585077

ABSTRACT

The aim of this study was to measure high-resolution strain fields in planar sections of brain tissue during translational acceleration to obtain validation data for numerical simulations. Slices were made from fresh, porcine brain tissue, and contained both grey and white matter as well as the complex folding structure of the cortex. The brain slices were immersed in artificial cerebrospinal fluid (aCSF) and were encapsulated in a rigid cavity representing the actual shape of the skull. The rigid cavity sustained an acceleration of about 900m/s(2) to a velocity of 4m/s followed by a deceleration of more than 2000m/s(2). During the experiment, images were taken using a high-speed video camera and Von Mises strains were calculated using a digital image correlation technique. The acceleration of the sampleholder was determined using the same digital image correlation technique. A rotational motion of the brain slice relative to the sampleholder was observed, which may have been caused by a thicker posterior part of the slice. Local variations in the displacement field were found, which were related to the sulci and the grey and white matter composition of the slice. Furthermore, higher Von Mises strains were seen in the areas around the sulci.


Subject(s)
Brain/pathology , Acceleration , Animals , Biophysics/methods , Brain/anatomy & histology , Brain Mapping/methods , Cerebrospinal Fluid/metabolism , Equipment Design , Female , Image Processing, Computer-Assisted , Models, Statistical , Optics and Photonics , Reproducibility of Results , Swine , Time Factors
3.
Thyroid ; 13(8): 819-22, 2003 Aug.
Article in English | MEDLINE | ID: mdl-14558925

ABSTRACT

DESIGN: The hormonal serum marker for the presence and course of patients with medullary thyroid cancer (MTC) is the mature calcitonin (CT) peptide. Other CALC-1 gene products such as the 116-amino acid polypeptide prohormone, procalcitonin, as well as its component calcitonin precursors (CTpr) may also be increased in their sera. We performed a study to evaluate the clinical utility of serum levels CTpr in these patients. METHODS: Twenty-one patients with MTC (9 males, 12 females; 23-76 years of age) were evaluated. The diagnosis was confirmed by histologic examination, except for 2 (a proven RET mutation plus an abnormal pentagastrin-stimulated CT level). Nine patients had postoperative hypercalcitoninemia and 3 of these died. The specific assay for mature CT was a commercial immunoradiometric assay (hCT-IRMA); the immunoluminometric assay for CTpr (B.R.A.H.M.S Diagnostica, Berlin, Germany) detects intact procalcitonin and the free CT:CT carboxypeptide-1. RESULTS: All patients had detectable serum CTpr. These levels considerably exceeded those of mature CT, averaging 7.6-fold greater. CTpr levels correlated positively with mature CT (r = 0.61; p < 0.001). After pentagastrin administration, there was a parallelism of response between the two assays. Whenever there were known metastases, CTpr increased markedly. CONCLUSION: This study demonstrates the universal presence of CTpr in the blood of patients with MTC. The measurement of these peptides may offer a new dimension to the clinical evaluation of this malignancy.


Subject(s)
Calcitonin/blood , Protein Precursors/blood , Thyroid Neoplasms/blood , Thyroid Neoplasms/diagnosis , Biomarkers, Tumor/blood , Calcitonin Gene-Related Peptide , Humans , Oncogene Proteins/genetics , Prognosis , Proto-Oncogene Proteins c-ret , Receptor Protein-Tyrosine Kinases/genetics , Reference Values , Retrospective Studies , Thyroid Neoplasms/genetics
4.
Eur J Clin Nutr ; 57(6): 727-34, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12792656

ABSTRACT

OBJECTIVES: To investigate if supplementation of preterm infant formula with a high docosahexaenoic acid/eicosapentaenoic acid (DHA/EPA) ratio together with alpha-linolenic acid (ALA) was able to maintain plasma and red blood cell DHA levels similar to that obtained with breast milk feeding without altering n-6 fatty acid status. DESIGN AND SUBJECTS: Preterm infants of mothers who elected not to breast feed (n=13) were assigned to ALA- and DHA-enriched formula (DHA group: DHA/EPA=5/l). Infants fed breast milk (n=25) constituted a reference group (BM group). Anthropometric and fatty acid parameters (plasma phospholipids, cholesterol esters, triglycerides and red blood cell phosphatidylethanolamine, PL, CE, TG, RBC-PE, respectively) were obtained after 2 days (D2) and 15 days (D15) of enteral feeding and at the 37th week (W37) of post-conception age and 1 month later (W37+30) in the DHA group. Mean DHA intake ranged between 16.5+/-1.6 and 17.9+/-2.9 mg/kg/day between D2 and W37+30. RESULTS: At W37, infant weights, heights, and head circumferences were similar in DHA and BM groups. PL DHA was maintained in the DHA group at the same level as in the BM group and the same for DHA in PE at W37. In RBC-PE and at W37, AA status was the same in both groups. In PL, AA levels remained very stable throughout the study; however, in the DHA group AA levels in PL remained in the range observed with standard formulas. CONCLUSION: The combined 18:3 n-3 and DHA supplementation of infant formula with DHA/EPA ratio 5/l is compatible with growth and n-3 fatty acid metabolism similar to that of preterm infants fed human milk.


Subject(s)
Docosahexaenoic Acids/pharmacology , Fatty Acids, Omega-3/metabolism , Growth/drug effects , Infant Food , alpha-Linolenic Acid/pharmacology , Dietary Supplements , Docosahexaenoic Acids/administration & dosage , Humans , Infant, Newborn , Infant, Premature , Milk, Human/metabolism , alpha-Linolenic Acid/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...